Elaine T Lam Selected Research

Elaine T Lam Research Topics

Disease

18	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 09/2014
17	Neoplasms (Cancer) 01/2022 - 12/2008
9	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 05/2012
6	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2015
4	Anemia 01/2022 - 11/2010
4	Fatigue 01/2020 - 11/2010
3	Disease Progression 01/2022 - 02/2012
2	Kidney Neoplasms (Kidney Cancer) 01/2022 - 11/2019
2	Brain Neoplasms (Brain Tumor) 12/2021 - 01/2021
2	Vomiting 09/2020 - 11/2010
2	Hypersensitivity (Allergy) 09/2020 - 03/2020
2	Nausea 09/2020 - 11/2010
2	Exanthema (Rash) 05/2020 - 11/2010
1	Hypercalcemia (Milk Alkali Syndrome) 01/2022
1	Teratoma (Teratoid Tumor) 10/2021
1	Nonseminomatous germ cell tumor 10/2021
1	Residual Neoplasm 10/2021
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021
1	Spinal Cord Compression 03/2020
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 03/2020
1	Triple Negative Breast Neoplasms 01/2020
1	Edema (Dropsy) 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Hypothyroidism 12/2016
1	Circulating Neoplastic Cells 05/2015
1	Carcinoma (Carcinomatosis) 02/2015
1	Thrombocytopenia (Thrombopenia) 11/2010
1	Neutropenia 11/2010

Drug/Important Bio-Agent (IBA)

5	Sunitinib (Sutent)FDA Link 01/2022 - 12/2016
5	Tyrosine Kinase InhibitorsIBA 10/2021 - 09/2014
4	AndrogensIBA 01/2021 - 12/2013
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 06/2015
3	Axitinib (AG 013736)IBA 01/2022 - 02/2015
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2014
3	Docetaxel (Taxotere)FDA Link 01/2022 - 11/2010
3	NivolumabIBA 01/2021 - 05/2020
3	Pharmaceutical PreparationsIBA 10/2019 - 06/2015
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 12/2018
2	avelumabIBA 01/2022 - 01/2021
2	sapanisertibIBA 01/2022 - 01/2020
2	pembrolizumabIBA 01/2022 - 01/2021
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 01/2020
2	cabozantinibIBA 12/2021 - 01/2019
2	IpilimumabIBA 01/2021 - 05/2020
2	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2020
2	atezolizumabIBA 01/2020 - 01/2020
2	Hormones (Hormone)IBA 12/2015 - 05/2015
2	Celecoxib (Celebrex)FDA Link 05/2012 - 12/2008
1	Biological ProductsIBA 01/2022
1	MTOR InhibitorsIBA 01/2022
1	CalciumIBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 10/2021
1	Immune Checkpoint InhibitorsIBA 10/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	enzalutamideIBA 01/2021
1	abirateroneIBA 01/2021
1	fosaprepitant FDA Link 09/2020
1	IronIBA 05/2020
1	CationsIBA 05/2020
1	Dapsone FDA Link 03/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2020
1	SteroidsIBA 03/2020
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 03/2020
1	Aurora Kinase AIBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	MLN 8237IBA 01/2020
1	PhytochemicalsIBA 12/2018
1	AntioxidantsIBA 12/2018
1	PT2385IBA 01/2018
1	TWEAK ReceptorIBA 01/2018
1	EnzymesIBA 01/2018
1	enavatuzumabIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Angiopoietin-1IBA 06/2015
1	trebananibIBA 06/2015
1	Angiopoietin-2IBA 06/2015
1	cixutumumabIBA 05/2015
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 05/2015
1	bicalutamide (Casodex)FDA LinkGeneric 05/2015
1	pazopanib FDA Link 02/2015
1	Interleukin-2 (IL2)IBA 09/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 03/2014
1	ON 01910IBA 03/2014
1	CateninsIBA 03/2014
1	Polo-Like Kinase 1IBA 03/2014
1	Epothilones (Epothilone)IBA 02/2012
1	KOS-1584IBA 02/2012
1	Suramin (Suramin Sodium)IBA 11/2010

Therapy/Procedure

17	Therapeutics 01/2022 - 11/2010
6	Drug Therapy (Chemotherapy) 10/2021 - 11/2010
4	Radiotherapy 03/2020 - 12/2013
3	Castration 01/2022 - 05/2015
2	Immunotherapy 01/2022 - 05/2020
1	Oral Administration 01/2022
1	Proton Therapy 01/2017
1	Nephrectomy 01/2016
1	Aftercare (After-Treatment) 11/2015
1	Prostatectomy (Retropubic Prostatectomy) 12/2013